Clinical characteristics | Mutation carriers (n = 9) | Non-mutation carriers (n = 64) | p |
---|---|---|---|
Age (years) | 59.8 ± 11 | 55,9 ± 12,2 | 0.017 |
Male n, (%) | 8 (88.9 %) | 50 (78.1 %) | 0.058 |
BMI (kg/m2) | 26.3 (24.0–29.4) | 28,0 (25.9–29.7) | 0.276 |
APOE genotype (%) | 0.336 | ||
ε2-ε3 | 33.3 | 17.2 | |
ε3-ε3 | 33.3 | 62.5 | |
ε3-ε4 | 33.3 | 14.1 | |
ε4-ε4 | 0 | 1.6 | |
ε4-ε2 | 0 | 4.7 | |
Triglycerides, mg/dL | 583 (529–1095) | 669 (580–848) | 0.416 |
Total cholesterol, mg/dL | 281 ± 48.9 | 262 ± 48.1 | 0.743 |
HDL cholesterol, mg/dL | 40.4 ± 9.67 | 40.1 ± 10.6 | 0.881 |
Diabetes, % | 11.1 | 26.6 | 0.314 |
Hypertension, % | 22.2 | 43.7 | 0.219 |
Cardiovascular disease, % | 22.2 | 14 | 0.522 |
Familial history (%) | 22.2 | 12.5 | 0.421 |